Childhood Meningioma — Trials

Childhood Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04239092	9-ING-41 in Pediatric Patients With Refractory Malignancies.	terminated	Phase 1	40	Actuate Therapeutics Inc.INDUSTRY	1	Jul 17, 2025	clinicaltrials
NCT02255461	Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors	terminated	Phase 1	35	Pediatric Brain Tumor ConsortiumNETWORK	1	Mar 2, 2021	clinicaltrials
NCT00326664	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Mar 7, 2016	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Data updated 22 days agoSource updated Jul 17, 2025source: clinicaltrials